SP3 and pachyonychia congenita: The expression levels of Sp1 are associated with tumor grade and M stage, and the expression levels of Sp3 were relevant to tumor grade and TNM stage (Tables S5 and S6) was observed by the clinicopathological characteristics analysis of PC patients.